SETBP1 and atypical chronic myeloid leukemia, BCR-ABL1 negative: However, the adverse prognostic value of SETBP1 mutations was not confirmed in two cohorts of patients with aCML and CMML, probably due to the fact that the median follow-up was relatively short (33).